CytoDyn Inc. (CYDY) IPO - S-1 Filing, Stock & Insider Activity

CytoDyn Inc. IPO - Status & S-1 Filing

Ticker: CYDY
Status: Registered - S-1 filed with the SEC
S-1 filed: 2026-04-22
Exchange: NASDAQ
Expected price range: $0.13–$0.41
Shares offered: 278,076,375
SEC CIK: 0001175680 · View the S-1 on SEC EDGAR →

CytoDyn Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.

Track every registration update on the InsiderAlpha IPO tracker.

Last SEC filing 2026-03-24

CytoDyn Inc. (CYDY) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every CYDY SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.

About CytoDyn Inc. (CYDY)

CytoDyn Inc. trades under the ticker CYDY. InsiderAlpha tracks 16 primary SEC Form 4 filings from 8 reporting insiders for CYDY since 2024, sourced directly from SEC EDGAR.

SEC CIK	0001175680

Recent CYDY Form 8-K Material Events

2026-04-30 - Item 7.01, 9.01 [SEC]
2026-03-24 - Item 1.01 · Financing · mixed [SEC]
CytoDyn extended the maturity dates of two secured convertible promissory notes (totaling $57 million in principal) by 36 months to April 2029, avoiding near-term default. In exchange, the company agreed to make monthly $1 million share payments to noteholders and reduced the ann
2026-03-05 - Item 3.02 · Financing · mixed [SEC]
CytoDyn completed a private placement of approximately 81.4 million units (common stock + warrants) for $17.5 million in gross proceeds at $0.2153 per unit. The offering represents a substantial equity raise for the company, with warrants exercisable at $0.26 per share over five

Recent Insider Filings

2026-03-24 - Tanya Durkee Urbach (Director)
2026-03-24 - Stephen M. Simes (Director)
2026-03-24 - Lishomwa C. Ndhlovu (Director)
2026-03-24 - Jacob P. Lalezari (Chief Executive Officer)
2026-03-24 - Robert E. Hoffman (Chief Financial Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CYDY insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CYDY Insider Trading - FAQ

What is the latest insider trade for CYDY?: CytoDyn Inc. (CYDY) had 0 insider filings in the last 90 days, with the most recent on 2026-03-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CYDY stock?: 0 insider purchases of CYDY were filed in the last 90 days.
How many insiders are selling CYDY stock?: 0 insider sales of CYDY were filed in the last 90 days.
Where can I see CYDY SEC filings (Form 4, 10-K, 10-Q, 8-K)?: This page tracks CYDY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Companies with Insider Activity

Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:

Learn More

Open the live CYDY dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.